Seeking Alpha

Vical (VICL) says the addition of its Vaxfectin adjuvant to Baxter's (BAX) influenza vaccines...

Vical (VICL) says the addition of its Vaxfectin adjuvant to Baxter's (BAX) influenza vaccines "substantially increases both antibody and T-cell responses." VICL's VP of vaccine research says seasonal influenza vaccines sometimes underperform in elderly patients — "a good adjuvant could" help, he adds. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)